Beyond Air
Beyond Air Secures $32 Million Financing: A Lifeline for Growth and a Catalyst for Stock Surge
Beyond Air, Inc. (NASDAQ: XAIR), a medical device and biopharmaceutical company at the forefront of nitric oxide (NO) therapies, announced on November 5, 2025, a significant financing deal of up to $32 million with Streeterville Capital. This strategic financial infusion, comprising a $12 million promissory note and a $20 million